Post-lesion administration of 7-NI attenuated motor and non-motor deficits in 6-OHDA induced bilaterally lesioned female rat model of Parkinson's disease

Neurosci Lett. 2015 Mar 4:589:191-5. doi: 10.1016/j.neulet.2014.12.030. Epub 2014 Dec 17.

Abstract

The preoperative neuroprotective effect of the 7-nitroindazole (7-NI) in 6-hydroxydopamine (6-OHDA) induced unilateral male animal models of Parkinson's disease (PD) has been widely reported. However, the therapeutic approach to PD pathology would be closely associated with the post-lesion treatment by 7-NI in 6-OHDA-induced bilateral model. Also, there is a scarcity of data on neuroprotective effect of 7-NI in PD in females. We have studied the neuroprotective effects of 7-NI in 6-OHDA-induced bilaterally lesioned female rats after short-term post-lesion treatment. Sprague-Dawley female rats with bilateral intraventricular injection of either 6-OHDA (10.5μg) (n=8-11/group) or saline (sham; n=8/group) at substantia nigra (SN) were provided with 7-NI (30mg/kg/day) intraperitoneal, once a day during the 3 consecutive days of short term treatment. 6-OHDA lesioned animals developed the motor and non-motor deficits, which were evaluated by behavioral and neuro-biochemical tests from the substantia nigra. Post-lesion administration of 7-NI reduced the motor deficits induced by 6-OHDA in the behavioral tasks such as Rota rod, open field test and forced swim test. Simultaneously, the dopamine levels were restored by 7-NI in post lesion animals up to 76% in comparison to 6-OHDA lesioned animals (23%). Furthermore, antioxidant-like effect of 7-NI was observed in lipid peroxidation, catalase, superoxide dismutase, and reduced glutathione tests. Conclusively, the present study showed that early postoperative administration of 7-NI attenuates the motor deficits induced by 6-OHDA in bilaterally lesioned female rat model of PD.

Keywords: 6-OHDA induced bilateral lesions; 7-Nitroindazole; Forced swim test; Parkinson’s disease; Post-lesion; Rota rod test.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Brain / drug effects
  • Brain / metabolism
  • Catalase / metabolism
  • Dopamine / metabolism
  • Female
  • Glutathione / metabolism
  • Indazoles / therapeutic use*
  • Lipid Peroxidation
  • Motor Skills / drug effects*
  • Neuroprotective Agents / therapeutic use*
  • Oxidopamine*
  • Parkinson Disease / drug therapy*
  • Parkinson Disease / etiology
  • Parkinson Disease / physiopathology
  • Rats, Sprague-Dawley
  • Superoxide Dismutase / metabolism

Substances

  • Indazoles
  • Neuroprotective Agents
  • Oxidopamine
  • Catalase
  • Superoxide Dismutase
  • Glutathione
  • 7-nitroindazole
  • Dopamine